Amylin receptor drugs for Type 2 Diabetes
3 tracked Amylin receptor drugs in the Type 2 Diabetes race. The class explanation lives on the Amylin receptor page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
1 approved / phase 42 Phase 3
Head-to-head evidence: cagrilintide vs cagrilintide/semaglutide · cagrilintide/semaglutide vs pramlintide